Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients

A Study of SHR0410 in Hemodialysis Patients With Pruritus

NCT04317209 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

NCT05342623 ·Status: TERMINATED ·Phase: PHASE3

A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus

NCT05525234 ·Status: UNKNOWN ·Phase: PHASE4

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis

NCT00833768 ·Status: TERMINATED ·Phase: PHASE3

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

NCT06747572 ·Status: ACTIVE_NOT_RECRUITING

A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

NCT03218501 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

NCT07098351 ·Status: RECRUITING ·Phase: NA

CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

NCT05356403 ·Status: TERMINATED ·Phase: PHASE3

Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis

NCT01736150 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

NCT00293202 ·Status: TERMINATED ·Phase: PHASE2

Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

NCT06939816 ·Status: TERMINATED ·Phase: PHASE2

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

NCT03802617 ·Status: COMPLETED ·Phase: PHASE2

The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial

NCT05482698 ·Status: COMPLETED ·Phase: PHASE2

Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05510115 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Montelukast for Treatment of Uremic Pruritus

NCT02559388 ·Status: COMPLETED ·Phase: NA

A Renal Impairment Study for PF-04965842

NCT03660241 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

NCT06598631 ·Status: WITHDRAWN ·Phase: PHASE2

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

NCT05075408 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy, Local Tolerance and Patient Acceptability of a Moisturizing Emollient in Patients With Uremic Xerosis

NCT01084720 ·Status: COMPLETED ·Phase: PHASE3

University of Michigan "Nephrology Research BioBank"

NCT00381121 ·Status: RECRUITING

Evaluation of Renastep

NCT03602937 ·Status: COMPLETED ·Phase: NA

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

NCT04527328 ·Status: COMPLETED ·Phase: NA

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

NCT04728984 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

NCT04235621 ·Status: TERMINATED

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT04344769 ·Status: RECRUITING